Related Experiment Videos
Clinical use of nefazodone in major depression: a 6-year perspective
Alan F Schatzberg1, Maureen R Prather, Martin B Keller
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Calif 94305-5717, USA. afschatz@Stanford.edu
The Journal of Clinical Psychiatry
|March 14, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions.
The American journal of psychiatry·2026
What are the clinical implications of mixed features in major depressive disorder? A VAST-D report.
Journal of psychopharmacology (Oxford, England)·2026
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report.
The Journal of clinical psychiatry·2026
The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.
Neuropsychiatric disease and treatment·2026
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trial.
Journal of affective disorders·2026
Using Speech to Develop Multivariable Prediction Models for Major Depressive Disorder and Generalized Anxiety Disorder During Pregnancy.
The Journal of clinical psychiatry·2026
Utilizing a Smartphone Application for Perinatal Depression Screening and Care Linkages: A Cross-Sectional Cohort Study.
The Journal of clinical psychiatry·2026
Evaluation of Sexual Function With Adjunctive Lumateperone in Patients With Major Depressive Disorder.
The Journal of clinical psychiatry·2026
Electroconvulsive Therapy and All-Cause Mortality, Nonsuicide Mortality, and Suicide Mortality.
The Journal of clinical psychiatry·2026
Pharmacotherapies for Co-Occurring Stimulant Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Network Meta-Analysis.
The Journal of clinical psychiatry·2026
Time Trends in Maternal Attention-Deficit/Hyperactivity Disorder and Medication Use in Pregnancy.
The Journal of clinical psychiatry·2026
A Gambling Financial Harm Screener (GFHS) for Payment Institutions: Multi-Method Development and Preliminary Validation.
Journal of gambling studies·2026
Psychotropic Medications and Kidney Disease: Balancing Efficacy, Safety, and Tolerability.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association·2026
Association of self-reported anxiety and depressive symptoms with incident hypertension among young adults.
Frontiers in cardiovascular medicine·2026